PCV70 - EFFECT OF TIME IN THERAPEUTIC RANGE ON COST AND CLINICAL OUTCOMES OF ATRIAL FIBRILATION PATIENTS - A COST-CONSEQUENCES ANALYSIS OF RIVAROXABAN VS WARFARIN FOR TURKEY
Abstract
Authors
G. Kockaya F. Cavus B. Ozin K.C. Yilmaz O. Ciftci G. Oguzhan Ergın A. Sharaf N. Buyuktuna T. Buyukisik M. Saylan